Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Effectiveness of Collaborative Services in Primary Care for Treating Children With Behavior Disorders (SKIP)
This study is currently recruiting participants.
Verified by National Institute of Mental Health (NIMH), September 2008
Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier: NCT00600470
  Purpose

This study will evaluate the effectiveness of a doctor-office collaborative care approach in treating children with disruptive behavior problems in the pediatric primary care setting.


Condition Intervention Phase
Attention Deficit and Disruptive Behavior Disorders
Behavioral: Doctor-office collaborative care (DOCC) management
Behavioral: Treatment as usual (TAU)
Phase I
Phase II

MedlinePlus related topics: Child Mental Health Mental Health
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study
Official Title: Collaborative Mental Health Services for Behavior Disorders in Primary Care

Further study details as provided by National Institute of Mental Health (NIMH):

Primary Outcome Measures:
  • Vanderbilt Parent ADHD Rating Scale; Child Health and Illness Profile; Pediatric Quality of Life Inventory; Individualized Goal Attainment Rating [ Time Frame: Measured at baseline and at Months 6, 12, 18, 24, and 30 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Parenting Stress Index; Brief Symptom Inventory; Alabama Parenting Questionnaire; Services Assessment for Children and Adolescents [ Time Frame: Measured at baseline and at Months 6, 12, 18, 24, and 30 ] [ Designated as safety issue: No ]

Estimated Enrollment: 263
Study Start Date: October 2007
Estimated Study Completion Date: March 2012
Estimated Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Doctor-office collaborative care management
Behavioral: Doctor-office collaborative care (DOCC) management
DOCC is an evidence-based psychosocial treatment approach that incorporates (1) adaptation of an evidence-based collaborative care approach using the chronic care model and participatory management theory to enhance training, implementation, and sustainability; (2) revised protocol content that includes medication management for ADHD, brief anxiety management, and attention to parental/partner dysfunction; (3) technological developments to facilitate screening/assessment, monitoring, and communication; and (4) an improved methodology that includes new samples, measures, and settings.
2: Active Comparator
Treatment as usual: psychoeducation and outside referral to treatment (PORT)
Behavioral: Treatment as usual (TAU)
TAU involves routine care: psychoeducation and referral to outside providers.

Detailed Description:

Disruptive behavior problems (DBP) involve a behavioral tendency of children and adolescents to continually disregard basic social rules and the rights of others. Symptoms of DBP include problematic aggression, antisocial tendencies, serious defiance of rules, and temper tantrums. Children or adolescents with DBP display this type of behavior at school, home, or other social situations, often affecting family life, academic performance, and relations with others. The causes of DBP are believed to be both environmental and biological. Children most at risk for DBP are those who have low birth weight, attention deficit hyperactivity disorder (ADHD), or a history of abuse or neglect. Behavioral therapy that targets parent and child skills has shown to be the most effective treatment for DBP. This study will evaluate the effectiveness of a doctor-office collaborative care (DOCC) approach in treating children with DBP in the pediatric primary care setting. The study is a continuation and extension of the parent study, Services for Kids in Primary Care (SKIP).

Participants in this single blind study will be randomly assigned to one of two treatment groups: doctor-office collaborative care (DOCC) or treatment as usual (TAU). Treatment will take place at one of eight participating primary care practices, each randomly assigned to either DOCC or TAU. All participants will undergo an initial assessment that will include a clinical evaluation with the care manager and research questionnaires. The families participating in the practices assigned to DOCC will receive cognitive behavioral therapy (CBT), parent management training (PMT), and ADHD management training. Participants will also complete ongoing behavioral questionnaires. There will be on average 12 DOCC sessions, lasting between 30 and 90 minutes, held in the primary care office. The sessions will occur over a 3- to 6-month period. The families participating in the practices assigned to TAU will receive a full review of initial assessment findings and specific recommendations for services in the community that would meet the clinical needs of the child participant. The parent/guardian of the child will also be provided psychoeducational resources via Web sites, literature, or reference materials. Lastly, participants in TAU will receive a follow-up call between 2 and 4 weeks after the initial assessment to assist with finding community programs or additional resource identification. All participants in both groups will undergo follow-up assessments at Months 6, 12, 18, and 30 after the initial assessment. Each assessment will last 2 to 3 hours and will include self-report and interview questionnaires.

  Eligibility

Ages Eligible for Study:   5 Years to 12 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Score of 75% on externalizing scale of PSC-17: score less than or equal to 6
  • Parent/guardian is concerned about the child's mental health
  • At least one parent/guardian who resides with the child is willing to participate in services and has signed an informed consent giving permission for the child to participate

Exclusion Criteria:

  • Child is currently prescribed and taking any of the following medications: SSRI, neuroleptics, antidepressants.
  • Emergent psychiatric conditions that require additional treatments (e.g., eating disorder/anorexia nervosa, substance dependence, PTSD-active phase, OCD, PDD/Autism/Aspergers)
  • Child has current suicidal or homicidal ideation with intent and a plan
  • Participation in ongoing outpatient services and plans to continue
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00600470

Contacts
Contact: Betsy A. Holden, MEd, LPC 412-246-5886 austines@upmc.edu

Locations
United States, Pennsylvania
Western Psychiatric Institute and Clinic (WPIC) Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contact: Betsy A. Holden, MEd, LPC     412-246-5886     austines@upmc.edu    
Sub-Investigator: Abigail B Schlesinger, MD            
Sub-Investigator: Stephen Wisniewski, PhD            
Sub-Investigator: Dana Rofey, PhD            
Sub-Investigator: David Wolfson, MD            
Sponsors and Collaborators
Investigators
Principal Investigator: David J. Kolko, PhD University of Pittsburgh
  More Information

Responsible Party: University of Pittsburgh School of Medicine ( David J. Kolko, PhD )
Study ID Numbers: 2R01 MH063272, DSIR 84-CTS
Study First Received: January 14, 2008
Last Updated: September 4, 2008
ClinicalTrials.gov Identifier: NCT00600470  
Health Authority: United States: Federal Government

Keywords provided by National Institute of Mental Health (NIMH):
Behavior Problems
Behavior Disorders

Study placed in the following topic categories:
Mental Disorders
Mental Disorders Diagnosed in Childhood
Attention Deficit and Disruptive Behavior Disorders

Additional relevant MeSH terms:
Pathologic Processes
Disease

ClinicalTrials.gov processed this record on January 30, 2009